Fragile X


Videos and audio are now exclusively available in the UC Davis MIND Institute Media Player. Adobe Flash and Javascript are needed to play back all media on the MIND Institute website. Chances are that Flash and Javascript are already a part of your browser as they are installed on almost all computers connected to the Internet. However, if you are having difficulty playing any media on this site, Adobe Flash can be downloaded from Adobe's website and instructions for enabling Javascript in your browser are available here. Get more information and help on using the new MIND Institute Media Player.

Special note for Internet Explorer 10 users: For media on this website to play back properly, be sure you are in "Compatibility View."

These webcasts are intended for personal, non-commercial use.  Please do not re-broadcast, re-encode, or otherwise distribute these webcasts without prior written permission from the UC Davis MIND Institute.

Updates in Research in Neurodevelopmental Disabilities

Updates in Research in Neurodevelopmental Disabilities

Updates in Research in Neurodevelopmental Disabilities

Presenters: Leonard Abbeduto, Ph.D., Randi J. Hagerman, M.D.,

Julie B. Schweitzer, Ph.D., and Christine Wu Nordahl, Ph.D.

Affiliation: UC Davis MIND Institute

Date: July 28, 2017

Length: 1:18:16

Summary: Keynote Address from 2017 Summer Institute. This panel of experts provided an update on some of the most current research in neurodevelopmental disabilities taking place at the UC Davis MIND Institute, including: using technology and parent partnerships to deliver language therapies into the homes of individuals affected by neurodevelopmental disorders, targeted treatments for neurodevelopmental disorders using fragile X syndrome as a model, developmental changes associated with ADHD and relevance to treatment and comorbid issues, as well as sex differences in the neurobiology of autism spectrum disorder.


Fragile X-associated Disorders and Targeted Treatments

Presenter: Randi J. Hagerman, M.D.

Affiliation: UC Davis MIND Institute

Date: May 1, 2016

Length: 40:20


MIND Institute faculty present their current research and its potential applications

Presenters: Randi Hagerman, M.D., Robin Hansen, M.D., Julie Schweitzer, Ph.D., and Tony Simon, Ph.D..

Affiliation: UC Davis MIND Institute

Date: November 17, 2011

Length: 1:19:53

Synopsis: Faculty will present research updates on autism, fragile X syndrome, Chromosome 22Q11.2 Deletion Syndrome, and Attention Deficit/Hyperactivity Disorder. Included in the discussion will be information about potential applications in preventing and treating these disorders.


Full and Premutations in Fragile X Syndrome: Translating New Science to Targeted Treatments in Autism and Neurodegenerative Disorders

Presenters: Randi Hagerman, M.D., Paul Hagerman, Ph.D., David Hessl, Ph.D. & Susan Rivera, Ph.D.

Affiliation: UC Davis MIND Institute

Date: November 18, 2010

Length: 1:25:24

Synopsis: The Fragile X Team discusses clinical involvement in patients with both the premutation and the full mutation including autism spectrum disorders, ADHD, anxiety, and premature ovarian failure. FXTAS (Fragile X Associated Tremor Ataxia Syndrome) and new targeted treatments for Fragile X Syndrome are also discussed.


Early Visual Processing Deficits in Fragile X and Autism

Presenter: Susan Rivera, Ph.D.

Affiliation: UC Davis MIND Institute

Date: August 6, 2010

Length: 1:25:35

Summary: Overview of early sensory development and neural underpinnings of visual processing strengths and weaknesses.


Nonverbal Cognitive Impairments in Various Neurodevelopmental Disorders: Implications for Learning

Presenter: Tony Simon, Ph.D.

Affiliation: UC Davis MIND Institute

Date: August 6, 2010

Length: 1:20:16

Summary: Emerging research on overlapping patterns of cognitive function in fragile x, Turner, and chromosome 22q11.2 deletion syndromes and their implications for intervention.


Developing Neurobehavioral Biomarkers for Targeted Treatment in Fragile X from Human and Animal Studies

Lecturers: Robert F. Berman, Ph.D., Susan Rivera, Ph.D., & Tony J. Simon, Ph.D.

Affiliation: UC Davis MIND Institute

Date: January 29, 2010

Length: 1:29:32

Synopsis: An overview of integrated neuroscience research efforts to study Fragile X-associated tremor ataxia (FXTAS). Specifically, the presentation will describe how studies in human FXTAS patients and basic science findings in transgenic mouse models of FXTAS have been integrated so that each informs the other to accelerate the pace of scientific discovery.


A New Age of Treatment for Fragile X Syndrome

Presenter: Randi Hagerman, M.D.

Affiliation: UC Davis MIND Institute

Date: August 7, 2009

Length: 58:05

Summary: Neurobiological abnormalities in Fragile X Syndrome, review of targeted treatments available and the mechanisms by which they work, with preliminary data regarding minocycline, fenobam, and R-baclofen.


New Targeted Treatments for Fragile-X Syndrome

Presenter: Randi Hagerman, M.D.

Affiliation: UC Davis MIND Institute

Date: August 8, 2008

Length: 1:20:21


Fragile X: A Family Affair

Presenters: Paul Hagerman, M.D.,Ph.D. & Randi Hagerman, M.D.

Affiliation: UC Davis MIND Institute

Date: January 17, 2008

Length: 1:41:28

Synopsis: It's hard to imagine, but defects in a single gene can cause mental impairment in children, premature ovarian failure in women and dementia in older adults. That gene -- the fragile X gene -- is the research focus of two MIND Institute investigators who are leading the way in discovering the molecular foundations of and new treatments for the broad spectrum of fragile X-related disorders. Hear more about what their work has revealed about the causes and outcomes of fragile X syndrome, their plans for new treatment trials and the benefits of their discoveries for understanding neurodevelopmental and neurodegenerative disorders.


Three Disorders, One Explanation? The Case of Cognitive Impairments in Fragile X Syndrome, Turner and Chromosome 22q11.2 Deletion Syndrome

Presenter: Tony Simon, Ph.D.

Affiliation: UC Davis MIND Institute

Date: Oct 16, 2008

Length: 1:07:28

Synopsis: Chromosome 22q11.2 deletion, Turner, and fragile X syndromes are different genetic disorders producing weakness in visuospatial, visuomotor and numerical cognition. 7 to 14 year old children with these disorders were studied to see if a common mechanism might be at work. Dr. Simon will present results from experimental cognitive and brain imaging studies that explain how children with these disorders think about space, time and number and suggest designs for therapeutic interventions.


What We Learn About Autism from Studying Fragile X Syndrome

Presenters: David Hessl, Ph.D., Lisa Cordeiro

Affiliation: UC Davis MIND Institute

Date: Jan 22, 2009

Length: 54:22

Synopsis: Individuals with autism and fragile X syndrome share many symptoms and there may be common neurobiological abnormalities underlying these symptoms. Dr. Hessl will share recent findings from his laboratory and others focusing on this topic and discuss implications that the overlapping features may have for the treatment of both conditions.


Presenter: Leonard Abbeduto, Ph.D.

Affiliation: University of Wisconsin, Madison

Date: May 9, 2007

Synopsis: Abbeduto Abstract »

4PM Lecture: Language Problems in Fragile X Syndrome: From Behavioral Phenotypes to Family Contexts
4PM Length: 1:11:47

6PM Lecture: Understanding the Communication Challenges of Youth with Fragile X Syndrome
6PM Length: 1:16:44

Research Guiding Psycho-pharmacologic Intervention in Fragile X and Fetal Alcohol Syndrome

Presenter: Randi Hagerman, M.D., F.A.A.P.

Affiliation: UC Davis MIND Institute

Date: August 4, 2005

Length: 1:03:18